Compare BIO & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | AXS |
|---|---|---|
| Founded | 1952 | 2001 |
| Country | United States | Bermuda |
| Employees | 7450 | 1876 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Property-Casualty Insurers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 8.0B |
| IPO Year | N/A | N/A |
| Metric | BIO | AXS |
|---|---|---|
| Price | $265.66 | $99.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $358.50 | $121.86 |
| AVG Volume (30 Days) | 237.8K | ★ 494.6K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.73% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $4.36 |
| Revenue Next Year | $3.05 | $6.20 |
| P/E Ratio | $9.72 | ★ $8.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $84.81 |
| 52 Week High | $343.12 | $110.34 |
| Indicator | BIO | AXS |
|---|---|---|
| Relative Strength Index (RSI) | 41.30 | 39.60 |
| Support Level | $239.33 | $98.77 |
| Resistance Level | $289.61 | $103.58 |
| Average True Range (ATR) | 7.68 | 1.98 |
| MACD | 0.48 | -0.25 |
| Stochastic Oscillator | 24.82 | 12.01 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.